Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

43,878 stories, page 582 of 732

Advanced search

🇺🇸Jul 7Researchclinicaltrials.govTier 1 · Trial registry

NCT06327477: Proton-Spatially Fractionated Radiotherapy and Standard Radiation Therapy for the Treatment of Newly Diagnosed Retroperitoneal Soft Tissue Sarcoma

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 7Researchclinicaltrials.govTier 1 · Trial registry

NCT05751486: A Clinical Study to Evaluate the Safety and Tolerability of JS001sc in Advanced Nasopharyngeal Carcinoma

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 7Researchclinicaltrials.govTier 1 · Trial registry

NCT05037968: MagnetOs Flex Matrix Compared to Trinity Elite Mixed With Local Autograft in Patients Undergoing up to Four-level Instrumented Posterolateral Fusion

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 7Researchclinicaltrials.govTier 1 · Trial registry

NCT04824859: A Geriatric Assessment Electronic Platform for Older Patients With Cancer (eGAP - Electronic Geriatric Assessment Platform)

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 7Researchclinicaltrials.govTier 1 · Trial registry

NCT04765150: Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 7Researchclinicaltrials.govTier 1 · Trial registry

NCT04437654: The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source

🇺🇸Jul 7Researchclinicaltrials.govTier 1 · Trial registry

NCT04315571: Comparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Controlled Expansion Stents

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 7Researchclinicaltrials.govTier 1 · Trial registry

NCT04083599: GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🌍Jul 7discoverynews.google.comTier 2 · Trade media

Novartis’ ADC gambit & regulation as catalyst for U.K. biotech — a BioCentury podcast

BioCenturyOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

FDA names former pharmaceutical company executive to oversee US drug program

MSNOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Why Biotech Cos. Need Litigation Plans Before Bad News

Law360Original source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Opus Genetics stock holds Buy rating at BTIG on gene therapy progress By Investing.com

Investing.com South AfricaOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

A former FDA official on antidepressants and suicide risk

KevinMD.comOriginal source

🌍Jul 7discoverynews.google.comTier 2 · Trade media

Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A booms

STATOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Texas Biomed teams up with UK-based biotech company to fight screwworm

Texas Public Radio | TPROriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Vera Therapeutics Jumps 9% as FDA Decision on Kidney Drug Looms

finance.biggo.comOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

VERAXA Biotech (VRXA) Highlights BiTAC Pipeline Progress, Advances Partnering Strategy

Yahoo FinanceOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Mizuho raises Revolution stock price target to $215 on cancer data By Investing.com

Investing.com South AfricaOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

B.Riley reiterates Buy on Opus Genetics stock on FDA alignment By Investing.com

Investing.com AustraliaOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?

The Motley FoolOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Novartis buys London-Boston biotech for up to $1.5B

The Business JournalsOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

New partnership aims to accelerate development of cystic fibrosis therapy

Cystic Fibrosis News TodayOriginal source

🌍Jul 7discoverynews.google.comTier 2 · Trade media

Roche pens $490m Astex breast cancer license deal

Pharmaceutical TechnologyOriginal source

🇪🇺Jul 7Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Minimally Invasive Neuromodulation Implant and implantation procedure based on ground-breaking GRAPHene technology for treating brain disorders

CORDISOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

The New Rules of Biotech Now Available in Hardcover and Audiobook

NewMediaWireOriginal source

🇪🇺Jul 7Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: SMART LIVING HOMES - WHOLE INTERVENTIONS DEMONSTRATOR FOR PEOPLE AT HEALTH AND SOCIAL RISKS

CORDISOriginal source

🇪🇺Jul 7Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Advancing a GMMA-based vaccine against invasive non-typhoidal salmonellosis through Phase 1 trial in Europe and sub-Saharan Africa

CORDISOriginal source

🇪🇺Jul 7Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Non-biased fluorescent dyes as markers of drugs for optical in cellulo and in vivo imaging

CORDISOriginal source

🇪🇺Jul 7Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Up-scaling the global univocal identification of medicines

CORDISOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

FDA accepts Pharvaris NDA for oral HAE attack treatment drug By Investing.com

Investing.com South AfricaOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

AtaiBeckley completes dosing in VLS-01 depression trial By Investing.com

Investing.com South AfricaOriginal source

🇺🇰Jul 7Regulatorygov.ukTier 1 · Regulatory source

Inadvertent vaccination in pregnancy (VIP)

Advice for health professionals on pregnant women who are inadvertently vaccinated against chicken p...

UK Health Security AgencyOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

HSBC Drops Pfizer to Hold: Seagen ADC Miss Leaves $43B Bet Without Catalyst

Tech TimesOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Biosimilar Race Heats Up for $48 Trillion Keytruda Market

조선일보Original source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Novartis acquires U.K. cancer biotech Myricx Bio for $1.5 billion

qz.comOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Northwell names entrepreneur Dr. Brian Kim biotech chief

Long Island Business NewsOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Why Are Drugmakers Racing to Acquire ADC Payload Platforms?

PharmTech.comOriginal source

🇺🇸Jul 6Industrycryoport.comTier 1 · Company source

Building the Foundation: Our New Global Supply Chain Center in Santa Ana, California

CryoportOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Can vibration therapy prevent bone loss?

UVA TodayOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

AstraZeneca PLC Stock (AZN) Moved Down by 3.79% on Jul 6: What Signal Does It Send?

TradingKeyOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Novartis Scoops up UK Biotech Myricx in $1.5 Billion Cancer Push

BenzingaOriginal source

🌍Jul 6Industrycibeles.com.uyTier 1 · Company source

STIGMAR DUO

Cibeles (Uruguay)Original source

🌍Jul 6Industrycibeles.com.uyTier 1 · Company source

Stigmar duo

Cibeles (Uruguay)Original source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Milestone Alert: Can-Fite Completes Enrollment in Phase 3 Trial of Oral Piclidenoson for Psoriasis

The Dermatology DigestOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

FDA Panel to Evaluate 7 Popular Peptides for Compounding Substances List

Drug TopicsOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Incidental Cavitary Pulmonary Mycobacterium avium Complex Disease With Possible Haemophilus influenzae Coinfection and Pharmacologic Barriers to Therapy: A Case Report

CureusOriginal source

🌍Jul 6discoverynews.google.comTier 2 · Trade media

Hair loss biotech Veradermics, up 656% since its IPO, credits the obesity boom

BioSpaceOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

New Haven biotech gets one-year notice that COVID therapy's emergency authorization will end

Hartford Business JournalOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

The NDAA Strengthens Government Support for Biotech. It Can Be Even Stronger.

The National InterestOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Revolution Medicines stock hits all-time high at 193.12 USD

Investing.com UKOriginal source

🌍Jul 6discoverynews.google.comTier 2 · Trade media

Beyond Boston: Unlikely cities stake biotech claims

BioPharma DiveOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

The Evolution and Impact of Patient Support Services: A Strategic Framework

Pharmaceutical CommerceOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Vertex Signs Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance for ALYFTREK for the Treatment of Cystic Fibrosis

Yahoo Finance SingaporeOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

First-in-Class Oral Piclidenoson Reaches Pivotal Phase 3 Enrollment Milestone in Plaque Psoriasis

Dermatology TimesOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Katalyze AI Raises $10.5M to Build the Agentic Operating System for Pharmaceutical Companies

WebWireOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Why This Biotech, Up 14% Since Its Breakout, Is On The Rise Once Again

Investor's Business DailyOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Regulatory round-up: 6 July 2026

The Pharma LetterOriginal source

🌍Jul 6discoverynews.google.comTier 2 · Trade media

Four major biotech updates to catch up on

STATOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Novartis To Buy UK Oncology Biotech For Up To $1.5B

Law360Original source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

AMP® BGTC Announces FDA Clearance of Investigational New Drug Application for Gene Therapy Targeting Multiple Sulfatase Deficiency

FNIHOriginal source